J. Reid et al., NO EFFECT OF KININS ON DNA-SYNTHESIS IN LNCAP PROSTATE-CANCER CELLS, Clinical and experimental pharmacology and physiology, 21(9), 1994, pp. 729-733
1. Prostate has kininogenase activity and expresses members of the tis
sue kallikrein gene family. The present study examined the effect of e
xogenous and endogenous kinins on growth of LNCaP prostate adenocarcin
oma cells. 2. Rate of DNA synthesis was measured by incorporation over
4 h of [H-3]-thymidine into a TCA insoluble fraction of LNCaP cells t
hat had been cultured for 24 h. 3. Increased [H-3]-thymidine incorpora
tion was seen in response to 10 nmol/L testosterone (+103+/-5 s.e.%),
dihydrotestosterone (+113+/-14%) and R1881 (+64+/-10%) (P less than or
equal to 0.001; n = 4). 4. In contrast 0.05, 5 and 1000 nmol/L lysyl-
bradykinin had no effect (15+/-4, 10+/-9 and 5+/-3 s.e.%, respectively
; n = 7). Des-Arg(9)[Leu(8)]-bradykinin (a B-1 receptor antagonist) an
d/or D-Arg-[Hyp(3),Thi(5,8),D-Phe(7)]-bradykinin (a B-2 receptor antag
onist), 1 nmol/L, and indomethacin, 5 mu mol/L, also had little or no
effect. 5. In conclusion, kallidin and endogenous kinins and prostagla
ndins have little or no effect on DNA synthesis and therefore on the g
rowth of LNCaP cells in comparison to the two-fold stimulation produce
d by androgens.